Teens with eating disorders get brain scans to test drug effects
NCT ID NCT05509257
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 23 times
Summary
This study looks at how a drug called naltrexone changes brain activity in teenagers aged 13-21 with eating disorders like bulimia or binge eating. Participants will have brain scans after taking either naltrexone or a placebo to see if the drug affects reward pathways. The goal is to develop a brain-based marker for how well the drug works, not to treat the disorder directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BINGE EATING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Children's Mercy Research Institute
RECRUITINGKansas City, Missouri, 64108, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.